MedPath

THE PROBIOTICS FOR ANTIBIOTIC ASSOCIATED DIARRHOEA (PAAD) STUDY Stage II : A double blind randomised placebo controlled trial to determine the effect of probiotics on antibiotic associated diarrhoea in care home residents.

Phase 1
Conditions
Antibiotic Associated Diarrhoea
MedDRA version: 14.1 Level: LLT Classification code 10055956 Term: Antibiotic-associated diarrhoea System Organ Class: 10017947 - Gastrointestinal disorders
Therapeutic area: Body processes [G] - Microbiological Phenomena [G06]
Registration Number
EUCTR2011-006269-17-GB
Lead Sponsor
Cardiff University, Research & Development Commercial Department
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

INCLUSION CRITERIA
•Resident in a care home for 24 hours or more, with a minimum planned residential care of 1 month.
•Able to provide informed consent or have a personal legal representative who can provide consent for inclusion.
•If the SU takes a regular probiotic but chooses to discontinue the probiotic

Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range 0
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 400

Exclusion Criteria

EXCLUSION CRITERIA
•Severely immuno-compromised, e.g. known severe neutropenia
•Has artificial heart valve in situ.
•Medical history of acute pancreatitis.
•Requires naso-jejunal feeding /nasogastric feeding due to difficulty of administering probiotic.
•Currently has a colostomy.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath